Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7287129 | 1.00 | KMT2A (0.58) | KMT2AMEN1NPSR1ACEMMP8 | |
| SCHEMBL9355043 | 0.95 | KMT2A (0.53) | KMT2AMEN1NPSR1ACEMMP8 | |
| SCHEMBL9355033 | 0.95 | KMT2A (0.53) | KMT2AMEN1NPSR1ACEMMP8 | |
| SCHEMBL7437830 | 0.89 | KMT2A (0.56) | KMT2AMEN1NPSR1MMP8FKBP1A | |
| SCHEMBL7437832 | 0.89 | KMT2A (0.56) | KMT2AMEN1NPSR1MMP8FKBP1A | |
| SCHEMBL7290435 | 0.87 | KMT2A (0.56) | KMT2AMEN1NPSR1MMP8FKBP1A | |
| SCHEMBL7290442 | 0.87 | KMT2A (0.56) | KMT2AMEN1NPSR1MMP8FKBP1A | |
| SCHEMBL9358799 | 0.87 | KMT2A (0.67) | KMT2AMEN1NPSR1MMP8FKBP1A | |
| SCHEMBL7326296 | 0.87 | KMT2A (0.67) | KMT2AMEN1NPSR1MMP8FKBP1A | |
| SCHEMBL9354888 | 0.86 | MEN1 (0.47) | KMT2AMEN1NPSR1ACEMMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602052-A1 | PROTEIN-BASED SIGNAL AMPLIFICATION | California Institute of Technology (US) | 2025-08-20 | — | — | EP | claimed |
| CN-119569898-A | Fusion protein, largemouth black bass virus subunit vaccine and application thereof | 湖北大学 | 2025-03-07 | — | — | CN | claimed |
| CN-119209702-A | Large signal stability analysis method for complex micro-grid | 电子科技大学 | 2024-12-27 | — | — | CN | claimed |
| CN-118604547-A | Intelligent online monitoring system for partial discharge of medium-high voltage cable and cable accessory | 江苏汉兴电缆有限公司 | 2024-09-06 | — | — | CN | claimed |
| WO-2024081912-A1 | PROTEIN-BASED SIGNAL AMPLIFICATION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-04-18 | — | — | WO | claimed |
| WO-2023225331-A1 | EXTENDED LIVE CELL BARCODING APPROACH FOR MULTIPLEXED MASS CYTOMETRY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-11-23 | — | — | WO | claimed |
| EP-3726756-B1 | CLOCK PRIORITY CHAIN LEVEL SYSTEMS AND METHOD | COMMSCOPE TECHNOLOGIES LLC (US) | 2022-07-06 | — | — | EP | claimed |
| WO-2022125590-A1 | A SYNTHETIC CIRCUIT FOR CELLULAR MULTISTABILITY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2022-06-16 | — | — | WO | claimed |
| WO-2026090414-A1 | SIRNA DELIVERY FOR POLYCYSTIC KIDNEY DISEASE THERAPY | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4709912-A1 | PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS | BioAtla, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260062435-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | WAVE LIFE SCIENCES LTD (SG) | 2026-03-05 | — | — | US | disclosed |
| US-12517846-B2 | Sharing memory and I/O services between nodes | INTEL CORPORATION (US) | 2026-01-06 | — | — | US | disclosed |
| EP-4646483-A1 | TREATMENT FOR OCULAR DISORDERS | Life Biosciences, Inc. (US) | 2025-11-12 | — | — | EP | disclosed |
| WO-2025227054-A1 | MONOCLONAL ANTIBODIES BINDING TO LEPTIN AND USES THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-10-30 | — | — | WO | disclosed |
| EP-0307837-A2 | Renin-inhibiting peptidyl heterocycles | ABBOTT LABORATORIES (US) | 1989-03-22 | — | — | EP | disclosed |
| EP-0300189-A2 | New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-01-25 | — | — | EP | disclosed |
| EP-0258289-A1 | PEPTIDE ANALOGS | ABBOTT LABORATORIES (US) | 1988-03-09 | — | — | EP | disclosed |
| WO-1987004349-A1 | PEPTIDE ANALOGS | DELLARIA JOSEPH | 1987-07-30 | — | — | WO | disclosed |
| EP-0230266-A2 | Functionalized peptidyl aminodiols and -triols | ABBOTT LABORATORIES (US) | 1987-07-29 | — | — | EP | disclosed |
| EP-0229667-A2 | Peptidylaminodiols | ABBOTT LABORATORIES (US) | 1987-07-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062435-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | NSUN3, METTL3, RNASE1 | KMT2A 2338/4885MEN1 4444/4885NPSR1 4239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.